In the Bivalirudin Era, Are We Still Looking for a Potent Antiplatelet Agent?

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|10|4|476-478

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.10, Iss.4, 2012-07, pp. : 476-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Synthetic isoxazole as antiplatelet agent

By Gutiérrez Margarita   Amigo Jessica   Fuentes Eduardo   Palomo Ivan   Astudillo Luis  

Platelets, Vol. 25, Iss. 4, 2014-06 ,pp. : 234-238

Informa Healthcare

Access to resources Recommend Favorite

Combined Antiplatelet Therapy: Still a Sweeping Combination in Cardiology

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 2, 2013-06 ,pp. : 136-167

Bentham Science Publishers

Access to resources Recommend Favorite

Antiplatelet therapy for atherothrombotic disease: How can we improve the outcomes?

By Moser Martin   Bode Christoph  

Journal of Thrombosis and Thrombolysis, Vol. 30, Iss. 2, 2010-08 ,pp. : 240-249

Springer Publishing Company

Access to resources Recommend Favorite

Antiplatelet and anticoagulant strategies in acute coronary syndrome: where we are in 2013

By Lumley Matthew   Perera Divaka  

Future Cardiology, Vol. 9, Iss. 3, 2013-05 ,pp. : 371-385

Future Medicine

Access to resources Recommend Favorite

Debate. Are we on the verge of a new era in ART?

By Felberbaum RE   Ludwig M   Diedrich K  

Human Reproduction, Vol. 13, Iss. 7, 1998-07 ,pp. : 1778-1780

Oxford University Press

Access to resources Recommend Favorite